Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to …
Over the last 12 months, insiders at Mesa Laboratories, Inc. have bought $0 and sold $927,651 worth of Mesa Laboratories, Inc. stock.
On average, over the past 5 years, insiders at Mesa Laboratories, Inc. have bought $100,000 and sold $11.51M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500 shares for transaction amount of $100,000 was made by Tripeny R Tony () on 2022‑08‑09.
2024-10-29 | Sale | President and CEO | 2,551 0.0469% | $111.98 | $285,651 | +3.33% | ||
2024-10-28 | Sale | President and CEO | 2,518 0.0395% | $113.62 | $286,085 | 0.00% | ||
2024-09-13 | Sale | SVP Operations | 1,499 0.0276% | $125.00 | $187,375 | +0.35% | ||
2023-12-15 | Sale | SVP Operations | 1,500 0.0282% | $112.36 | $168,540 | -3.48% | ||
2023-09-15 | Sale | director | 1,000 0.0187% | $123.74 | $123,740 | -16.04% | ||
2023-09-14 | Sale | director | 3,000 0.0546% | $123.05 | $369,150 | -17.81% | ||
2023-09-13 | Sale | director | 3,000 0.0559% | $123.32 | $369,965 | -15.96% | ||
2023-09-01 | Sale | President and CEO | 2,000 0.0378% | $142.82 | $285,640 | -26.49% | ||
2023-03-24 | Sale | CFO | 1,128 0.0207% | $167.01 | $188,387 | -33.79% | ||
2023-03-22 | Sale | CFO | 2,500 0.0475% | $171.62 | $429,050 | -32.59% | ||
2023-03-15 | Sale | CFO | 1,000 0.0185% | $165.71 | $165,710 | -27.44% | ||
2023-03-09 | Sale | CFO | 400 0.0074% | $169.97 | $67,988 | -28.71% | ||
2023-02-09 | Sale | CFO | 1,000 0.0194% | $184.27 | $184,270 | -28.41% | ||
2023-01-23 | Sale | CFO | 2,100 0.0409% | $210.19 | $441,399 | -35.30% | ||
2023-01-13 | Sale | director | 1,571 0.0295% | $191.31 | $300,548 | -30.23% | ||
2022-12-08 | Sale | director | 230 0.0042% | $174.97 | $40,244 | -21.31% | ||
2022-11-11 | Sale | director | 2,500 0.0455% | $175.45 | $438,625 | -12.30% | ||
2022-08-18 | Sale | 3,692 0.0685% | $196.12 | $724,075 | -16.71% | |||
2022-08-16 | Sale | CFO | 1,372 0.0258% | $200.58 | $275,196 | -17.28% | ||
2022-08-15 | Sale | CFO | 628 0.0118% | $200.54 | $125,939 | -16.97% |
SEG Ventures, LLC | director | 200000 3.6823% | $100.01 | 4 | 0 | |
CAMPBELL H STUART | director | 41527 0.7646% | $100.01 | 1 | 22 | <0.0001% |
Dwyer Robert V | director | 35696 0.6572% | $100.01 | 2 | 26 | |
GUILLEMIN EVAN | 28776 0.5298% | $100.01 | 4 | 19 | ||
Sullivan John James | director | 23857 0.4392% | $100.01 | 5 | 35 |
BlackRock | $91.18M | 15.36 | 830,988 | -1.76% | -$1.63M | <0.01 | |
Conestoga Capital Advisors, LLC | $63.73M | 10.74 | 580,744 | +0.39% | +$250,294.28 | 0.94 | |
The Vanguard Group | $40.97M | 6.9 | 373,397 | +0.84% | +$342,247.87 | <0.01 | |
ROYCE & ASSOCIATES INC | $31.13M | 5.25 | 283,739 | +5.23% | +$1.55M | 0.28 | |
Morgan Stanley | $27.59M | 4.65 | 251,424 | -3.79% | -$1.09M | <0.01 |